Sprint Bioscience AB
F:5JA1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sprint Bioscience AB
F:5JA1
|
SE |
|
Hiab Oyj
F:C1C1
|
FI |
|
C
|
CVB Financial Corp
F:BCV
|
US |
|
B
|
Borr Drilling Ltd
OSE:BORR
|
BM |
|
ConvaTec Group PLC
LSE:CTEC
|
UK |
|
L
|
LTC Properties Inc
SWB:LTP
|
US |
|
U
|
Unilever PLC
XMUN:UNVB
|
UK |
|
Yamaha Motor Co Ltd
TSE:7272
|
JP |
|
N
|
Noah Holdings Ltd
HKEX:6686
|
CN |
|
X
|
Xilio Therapeutics Inc
NASDAQ:XLO
|
US |
|
Eagle Materials Inc
NYSE:EXP
|
US |
|
Exxaro Resources Ltd
OTC:EXXAF
|
ZA |
|
C
|
Capitol Federal Financial Inc
F:CFW
|
US |
|
C
|
Coty Inc
XMUN:CO3A
|
US |
|
K
|
Kirin Holdings Co Ltd
XMUN:KIR
|
JP |
|
A
|
Ambev SA
BMV:ABEVN
|
BR |
|
H
|
Haier Smart Home Co Ltd
F:690D
|
CN |
|
Outlook Therapeutics Inc
NASDAQ:OTLK
|
US |
|
Kirin Holdings Co Ltd
F:KIR
|
JP |
Bankruptcy Probability
Sprint Bioscience AB's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sprint Bioscience AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
S
|
Sprint Bioscience AB
STO:SPRINT
|
289.1m SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
211.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
180.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
81.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sprint Bioscience AB's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sprint Bioscience AB has no debt.
You can find a full breakdown on its Balance Sheet.
